Apr 3, 2018 - Oncotarget. 17979 www.oncotarget.com www.oncotarget.com. Oncotarget, 2018, Vol. ... nanoparticles with photodynamic therapy. Wei Shi1,2,* ...
www.oncotarget.com
Oncotarget, 2018, Vol. 9, (No. 25), pp: 17979-17979
Correction
Correction: A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy Wei Shi1,2,*, Yanxue Yin1,2,*, Yao Wang3,*, Bo Zhang1,2, Pei Tan1,2, Ting Jiang1,2, Heng Mei1,2, Jun Deng1,2, Huafang Wang1,2, Tao Guo1,2, Zhiqing Pang3 and Yu Hu1,2 1
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China 2
Targeted Biotherapy Key Laboratory of Ministry of Education, Wuhan, Hubei, China
3
Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China 4
Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China
*
These authors have contributed equally to this work
Published: April 03, 2018 Copyright: Shi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: The proper name of the institution is as follows: 1
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China
Original article: Oncotarget. 2017; 8:32212-32227. https://doi.org/10.18632/oncotarget.12922
www.oncotarget.com
17979
Oncotarget
